Photo by Myriam Zilles on Unsplash
03 July, 2023
Beijing Sinotau International Pharmaceutical Technology (Sinotau) has secured over 1.1 billion yuan ($151.8 million) in a new funding round to advance the R&D and clinical trials of its radiopharmaceutical pipeline, the firm announced on Monday.
Edited by: Pramod Mathew
Continue reading this premium story with a subscription to DealStreetAsia.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
Printed by Unregistered user on Thu, 13 Jul 2023 16:34:16 GMT
Bring stories like this into your inbox every day.
Sign up for our newsletter – The Daily Brief
Related Stories
The healthcare-focused investor is looking to start fundraising for new vehicle early next year.
VIVA Biotech will use the proceeds to redeem convertible bonds and settle its outstanding liabilities.